These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8922488

  • 1. Piracetam is useful in the treatment of children with sickle cell disease.
    el-Hazmi MA, Warsy AS, al-Fawaz I, Opawoye AO, Taleb HA, Howsawi Z, Mohamed AA, Aly AW, Refai S, Sugathan PS, Rab AS, Ahmed HB, Abulaban M, Abdulkader AM, Farid M.
    Acta Haematol; 1996; 96(4):221-6. PubMed ID: 8922488
    [Abstract] [Full Text] [Related]

  • 2. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease.
    Alvim RC, Viana MB, Pires MA, Franklin HM, Paula MJ, Brito AC, Oliveira TF, Rezende PV.
    Acta Haematol; 2005; 113(4):228-33. PubMed ID: 15983428
    [Abstract] [Full Text] [Related]

  • 3. Painful crises in children with sickle cell disease are not prevented by piracetam.
    Viana MB, Alvim RC.
    Acta Haematol; 2009; 121(1):9-10. PubMed ID: 19246889
    [No Abstract] [Full Text] [Related]

  • 4. Piracetam and acetamide in sickle-cell disease.
    de Araujo JT, Nero GS.
    Lancet; 1977 Aug 20; 2(8034):411. PubMed ID: 70630
    [No Abstract] [Full Text] [Related]

  • 5. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T, Ohnishi ST, Adachi K, Ozguc M, Hashimoto K, Devlin MT, Schwartz E.
    Biochim Biophys Acta; 1981 May 29; 668(3):397-405. PubMed ID: 7236716
    [Abstract] [Full Text] [Related]

  • 6. Hydroxyurea for the treatment of sickle cell disease.
    el-Hazmi MA, Warsy AS, al-Momen A, Harakati M.
    Acta Haematol; 1992 May 29; 88(4):170-4. PubMed ID: 1292305
    [Abstract] [Full Text] [Related]

  • 7. Use of piracetam improves sickle cell deformability in vitro and in vivo.
    Gini EK, Sonnet J.
    J Clin Pathol; 1987 Jan 29; 40(1):99-102. PubMed ID: 3818978
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparative study of haematological parameters in children suffering from sickle cell anaemia (SCA) from different regions of Saudi Arabia.
    El-Hazmi MA, Warsy AS.
    J Trop Pediatr; 2001 Jun 29; 47(3):136-41. PubMed ID: 11419675
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of alpha thalassaemia, G-6-PD deficiency and Hb F on the nature of sickle cell anaemia in south-western Saudi Arabia.
    el-Hazmi MA, al-Swailem AR, Bahakim HM, al-Faleh FZ, Warsy AS.
    Trop Geogr Med; 1990 Jul 29; 42(3):241-7. PubMed ID: 1705730
    [Abstract] [Full Text] [Related]

  • 12. Erythrocyte - endothelial cell adherence in sickle cell disease, diabetes mellitus, and falciparum malaria: adverse effects reversed with piracetam.
    Nalbandian RM, Henry RL, Fleischman JA, Burek L, Williams G, O'Donnell FE, Diglio CA, Collier BD, Reeser FH.
    Med Hypotheses; 1982 Feb 29; 8(2):155-62. PubMed ID: 7045599
    [Abstract] [Full Text] [Related]

  • 13. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A, Ebrahim GJ.
    J Trop Pediatr; 2003 Jul 29; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [Abstract] [Full Text] [Related]

  • 14. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
    Wang WC, Morales KH, Scher CD, Styles L, Olivieri N, Adams R, Brambilla D, STOP Investigators.
    J Pediatr; 2005 Aug 29; 147(2):244-7. PubMed ID: 16126058
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells.
    Sawires H, Botrous O.
    Eur J Pediatr; 2012 Jul 29; 171(7):1063-7. PubMed ID: 22302459
    [Abstract] [Full Text] [Related]

  • 16. [Trial prevention of vaso-occlusive crises in homozygote sickle cell anemia using piracetam].
    Sonnet J, Gini EK, Cornu G.
    Ann Soc Belg Med Trop; 1985 Jul 29; 65(1):77-84. PubMed ID: 4004377
    [No Abstract] [Full Text] [Related]

  • 17. [Effectiveness and acceptance of hydroxyurea in the treatment of severe forms of sickle cell disease: a prospective study of 65 cases].
    Mellouli F, Chouaibi S, Dhouib N, Ouederni M, Ben Khaled M, Abbes S, Bejaoui M.
    Tunis Med; 2013 Jul 29; 91(8-9):544-50. PubMed ID: 24227514
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Piracetam: a review of pharmacological properties and clinical uses.
    Winblad B.
    CNS Drug Rev; 2005 Jul 29; 11(2):169-82. PubMed ID: 16007238
    [Abstract] [Full Text] [Related]

  • 20. Tuberculosis in children with sickle cell anaemia: a retrospective study in French tertiary care centres.
    Droz N, De Lauzanne A, Holvoet L, Missud F, Benkerrou M, Brousse V, Odièvre MH, Faye A, Koehl B.
    Eur J Pediatr; 2017 Jun 29; 176(6):723-729. PubMed ID: 28401342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.